1) B2 crystal structure
B2晶体结构
2) B2 structure
B2结构
3) Crystal structure
晶体结构
1.
Synthesis and crystal structure [Cd(phen)_3]_2[PMo~ⅤMo_(11)~ⅥO_(40)] and H_3O[Co(phen)_3]_2[PMo_2~ⅤMo_(10)~ⅥO_(40)];
[Cd(phen)_3]_2[PMo~ⅤMo_(11)~ⅥO_(40)]和H_3O[Co(phen)_3]_2[PMo_2~ⅤMo_(10)~ⅥO_(40)]的合成与晶体结构
2.
Synthesis and Crystal Structure of Zn(Ⅱ) Complex between Bis(3,5-Dinitrobenzoic Acid) and Bis(1,10-phenanthroline);
二(3,5-二硝基苯甲酸)双(1,10-二氮杂菲)锌(Ⅱ)配合物的合成及晶体结构
3.
Synthesis and crystal structure of 2,5-bis(2,4-die thylbenzoyl) terephthalic acid;
2,5-二(2,4-二乙基苯甲酰基)对苯二甲酸的合成及晶体结构
4) crystalline structure
晶体结构
1.
Effect of different synthesizing methods on LiMn_2O_4 and its derivatives’ crystalline structure and electro-chemical properties;
合成方法对LiMn_2O_4及其衍生物的晶体结构及电化学性能的影响
2.
Effect of different raws on LiCo_(0.05)Mn_(1.95)O_4 s crystalline structure and electro-chemical properties;
不同原料对锂离子电池正极材料LiCo_(0.05)Mn_(1.95)O_4的晶体结构及电化学性能的影响
5) crystal structures
晶体结构
1.
The development of CAI software of crystal structures;
晶体结构CAI软件的研制
2.
Two new dinuclear ternary complexes, [Cu_2(L~1)(Phen)_4](ClO_4)_4 (1) and [Mn_2(L~2)_2(Phen)_4]-(ClO_4)_2(2) (Phen=1,10-Phenanthroline, L~1=benzotriazole, L~2=4-quinolinecarboxylic acid) have been synthesized and characterized, and their crystal structures have been determined.
合成了含邻菲咯啉的三元混配的双核酮、锰配合物:[Cu2(L1)(Phen)4](C lO4)4(1)和[M n2(L2)2(Phen)4](C lO4)2(2)(Phen=邻菲咯啉,L1=苯并三氮唑,L2=4-喹啉羧酸),并用X-射线单晶衍射法测定了它们的晶体结构。
3.
The crystal structures of two isomers (m2[ZnCl4] and m4 [ZnCl4]) have been determined by single-crystal X-ray diffraction method.
88）体系中的 2个异构体的晶体结构。
6) structure
[英]['strʌktʃə(r)] [美]['strʌktʃɚ]
晶体结构
1.
Synthesis,characterization and crystal structure of 1,2-bis[3-(6,8-di-tert-butyl-3,4-dihydro-2[H]-1,3-benzoxazine)-yl]ethane;
1,2-二[3-(6,8-二叔丁基-3,4-二氢-1,3-苯并噁嗪)基]乙烷的合成及晶体结构
2.
Influence of Substrate Temperature on the Structure and Electric Properties of ZnO Films;
衬底温度对ZnO薄膜晶体结构和电学性质的影响研究
3.
Synthesis and Crystal Structure of Aluminium Complex with 3 Hydroxyflavone;
三(3-羟基黄酮)合铝(Ⅲ)的合成及晶体结构
补充资料：[3-(aminosulfonyl)-4-chloro-N-(2.3-dihydro-2-methyl-1H-indol-1-yl)benzamide]
分子式：C16H16ClN3O3S
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条